Marsh & McLennan Cos.: 2Q26: Solid Execution Offsetting Softer Pricing Outlook

Research evidence excerpt

Marsh & McLennan Cos.: 2Q26: Solid Execution Offsetting Softer Pricing Outlook

Equity Research

North America Insurance/Non-Life

22 July 2026

Marsh & McLennan Cos.

2Q26: Solid Execution Offsetting

Softer Pricing Outlook

Overall results were constructive, with RIS results in line and MRSH OVERWEIGHT

Consulting above expectations. Capital returns remained Unchanged

North America Insurance/

stronger and can offer upside on increased deployment, Non-Life NEUTRAL

Unchanged

although softer pricing and talent reinvestment modestly Price Target USD 206.00

Unchangedtempers our outlook for organic growth and margins.

Price (21-Jul-26) USD 181.59

Potential Upside/Downside +13.4%We view the 2Q26 print as constructive, with solid execution offsetting a more-difficult

Source: Bloomberg, Barclays Research

pricing backdrop, although softer market conditions raise questions around the organic

growth trajectory, particularly in reinsurance. RIS organic growth met our expectations,

Market Cap (USD mn) 86656while Consulting came in ahead, led by 13% growth at Marsh Management Consulting.

Shares Outstanding (mn) 477.21Buybacks exceeded our forecast, and the $500mn increase in planned capital deployment to

Free Float (%) 99.90$5.5bn provides additional flexibility for M&A or repurchases. Management maintained its

52 Wk Avg Daily Volume (mn) 2.8margin expansion outlook, with greater improvement expected in 4Q than 3Q, as producer and

Dividend Yield (%) 2.18technology investments limit near-term flow-through. AI investments are becoming more

Return on Equity TTM (%) 25.51targeted, with Marsh Risk Companion and Coverage Intelligence supporting client analytics and

Current BVPS (USD) 32.29producers, Claims IQ supporting 3,000 claims professionals, Lenwork assisting with product

Source: Bloomberg